This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked PPP1CB Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-PPP1CB WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~37.2 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Appendix (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The M04022-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | Jurkat cell lysate (catalog M04022-1) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M04022-1; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
PPP1CB is predicted at 37.2 kDa; its annotated modifications could affect migration, but no empirical band or visible shift is established.
| Single band near 37.2 kDa | Consistent with full-length PPP1CB; confirm identity with a specific control |
| Band near 37.2 kDa in cytoplasmic fraction | Consistent with its documented cytoplasmic localization |
| Band near 37.2 kDa in nuclear fraction | Consistent with its documented nuclear localization |
| Possible close doublet near 37.2 kDa | Thr316 phosphorylation could affect migration, but a doublet is not established |
| UniProt predicted mass | Places the full-length protein near 37.2 kDa |
| 327-residue sequence | Defines the full-length protein underlying the 37.2 kDa prediction |
| N-acetylalanine at residue 2 | Is annotated, with no demonstrated visible size shift |
| Phosphothreonine at residue 316 | Could affect migration, but no band shift is demonstrated |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | PPP1CB can occur in cytoplasmic and nuclear compartments | Check both fractions and a suitable positive lysate |
| Band higher than expected | Its identity or migration is uncertain; no glycosylation or disulfide-linked dimer is annotated | Confirm identity with PPP1CB depletion or a second antibody |
| Band lower than expected | Its identity is uncertain; no signal peptide or propeptide cleavage is annotated | Confirm identity with PPP1CB depletion or a second antibody |
| Multiple bands | Thr316 phosphorylation could contribute, but distinct bands are not established | Compare phosphatase-treated samples and confirm band identity |
| Weak or no signal | PPP1CB may be distributed between cytoplasmic and nuclear compartments | Check fraction recovery and a suitable positive lysate |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Appendix | endocrine cells | High | Protein (IHC) | HPA → |
| Gallbladder | glandular cells | High | Protein (IHC) | HPA → |
| Rectum | endocrine cells | High | Protein (IHC) | HPA → |
| Small intestine | endocrine cells | High | Protein (IHC) | HPA → |
| Breast | glandular cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Hippocampus | glial cells | Not detected | Protein (IHC) | HPA → |
| Parathyroid gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Skeletal muscle | myocytes | Not detected | Protein (IHC) | HPA → |
| Spleen | cells in red pulp | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for PPP1CB, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Two the supplier monoclonal anti-PPP1CB antibodies have WB images: M04022-1 in Jurkat lysate and A04022-1 in mouse brain, F9, and MCF7 lysates. These examples do not establish WB performance across every listed reactive species.
Which to pick: Choose M04022-1 for a Jurkat lysate precedent, or A04022-1 for a mouse brain, F9, or MCF7 lysate precedent. A04022-1 lists broader species reactivity, but the supplied WB image does not demonstrate every listed species.